Compare GEF & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GEF | ICUI |
|---|---|---|
| Founded | 1877 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.6B |
| IPO Year | N/A | 1992 |
| Metric | GEF | ICUI |
|---|---|---|
| Price | $70.40 | $153.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $72.50 | ★ $179.50 |
| AVG Volume (30 Days) | ★ 232.0K | 217.4K |
| Earning Date | 01-27-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.12% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,290,654,188.00 | $2,320,363,000.00 |
| Revenue This Year | $2.73 | N/A |
| Revenue Next Year | $1.63 | N/A |
| P/E Ratio | $3.71 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $48.23 | $107.00 |
| 52 Week High | $72.45 | $175.51 |
| Indicator | GEF | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 58.57 | 62.44 |
| Support Level | $70.53 | $146.33 |
| Resistance Level | $72.45 | $157.91 |
| Average True Range (ATR) | 1.67 | 5.16 |
| MACD | -0.09 | 0.54 |
| Stochastic Oscillator | 77.03 | 86.04 |
Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.